今天分享的是：跨境电商运营：2024中国宠物产业出海分析报告 Global E-Pa 2024 中国宠物产 出海分 热门出口国家及海外市场分析 Global E-Payment 中国宠物产业出海报告 | Global E-Payment 1. 行业概况 粮:干湿粮、生食食品(BARF)、小 动物食品(如仓鼠、鸟类等)、零食等 饮：水碗、食物与水的自动供应器等 报告共计：20页 中国宠物产业加速出海，2023年出口总额达58亿美元，2024年预计突破65亿美元。其中，宠物食品占比55%，主攻欧美高端市场，冻干粮等增速超30%；宠 物用品占35%，智能项圈等成技术出口主力，北美订单占比45%；宠物健康产品占10%，在东南亚需求激增。美国作为全球宠物经济第一大国，占据全球宠 物市场40%份额，家庭渗透率达70%，是中国宠物产品重要出口地，2023年中国对美宠物食品出口额同比增长18.2% 。此外，欧洲、东南亚、日韩等也是主 要市场。在欧洲，环保需求使中国PLA生物基材料企业订单翻倍，但碳关税让宠物塑料用品出口成本上升810%。东南亚中产阶级养宠家庭超4000万户，电 商平台Lazada宠物类目GMV增长60%，不过 ...

Core Viewpoint - Reap Bio plans to divest 48.4213% of its stake in Zhong'an Bio due to the latter's failure to achieve expected returns from a fundraising project and the company's shift towards the pet business [1][2][3] Group 1: Divestment Details - Reap Bio will transfer its controlling stake in Zhong'an Bio to Jiangxi Twin Biological Technology Co., with the transaction price set at 115 million yuan, reflecting a 15.3% premium on the overall valuation of 237 million yuan [2][3] - Zhong'an Bio, established in 2010, primarily produces livestock vaccines, with an annual production capacity of approximately 300 million doses [2] Group 2: Financial Performance - In 2024, Zhong'an Bio reported a revenue of 48.98 million yuan, down nearly 12% year-on-year, and incurred a loss of 459,600 yuan [3][8] - The net asset value of Zhong'an Bio was reported at 206 million yuan as of 2024 [2] Group 3: Strategic Shift - Reap Bio's divestment is part of a broader strategy to focus on its core business and mitigate losses from underperforming assets [3][6] - The company has been actively acquiring stakes in the pet industry, including a 15% stake in Zhongrui Huapu Technology for 131 million yuan, indicating a strategic pivot towards the pet supply chain [4][7] Group 4: Financial Risks - Reap Bio's short-term interest-bearing liabilities reached 862 million yuan in 2024, a 55% increase year-on-year, while long-term loans rose by 67% to 514 million yuan [5] - The company's asset-liability ratio increased from 27% to 37%, indicating growing financial leverage [5] Group 5: Profitability Challenges - In 2024, Reap Bio's net profit declined by 33.7%, attributed to rising raw material costs, increased R&D and financial expenses, and a significant drop in non-recurring gains [8] - The overall gross margin fell from 49.69% in 2023 to 41.38% in 2024, reflecting pressure on profitability [8] Group 6: Operational Concerns - Accounts receivable rose to 1.07 billion yuan, and inventory increased from 390 million yuan to nearly 500 million yuan, indicating potential liquidity issues [9] - The company's ability to successfully integrate and grow its pet business will be critical for its long-term performance amid current challenges [9]

星标 ★ IPO日报 精彩文章第一时间推送 "宠物代工龙头"天元宠物披露了收购案的最新进展。 5月29日晚间，杭州天元宠物用品股份有限公司(下称"天元宠物"，301335.SZ)发布公告称，上市 公司拟通过发行股份及支付现金的方式购买广州淘通科技股份有限公司（以下简称"淘通科技"） 89.7145%股权，交易作价68756.67万元，其中以发行股份和现金方式支付的对价金额分别为 24904.06万元和43852.61万元。 同时，上市公司拟向不超过35名符合条件的特定对象发行股份募集配套资金，募集配套资金总额不 超过24904.06万元，用于支付本次交易的现金对价。 本次交易构成重大资产重组。本次交易不会导致公司控制权变更，不构成重组上市。 本次交易完成后，淘通科技将成为上市公司的控股子公司。 AI制图 对比7年前，标的公司的收入规模和净利润规模均实现了较大飞跃。 本次交易中，业绩承诺方向上市公司承诺，2025年—2027年，标的公司实现的净利润分别不低于 7000万元、7500万元和8000万元。 根据坤元评估出具的标的资产评估报告，以2024年12月31日为评估基准日，在持续经营的假设前 提下，经收益法评 ...